Evidence map›Paper›PMID 40056195›Full record

ArticleArchives of dermatological research2025

Comparative study between botulinum toxin and topical steroid in treatment of psoriasis vulgaris.

Amel Raouf Hassan, Mai Tarek Anwar, Noha Ezzat Mohamed

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Archives of dermatological research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Amel Raouf HassanDepartment of Dermatology, STDs & Andrology, Faculty of Medicine, Fayoum University, Fayoum, Egypt. arh11@fayoum.edu.eg.
Mai Tarek AnwarDepartment of Dermatology, Faculty of Medicine, Fayoum University, Fayoum, Egypt.
Noha Ezzat MohamedDepartment of Dermatology, Faculty of Medicine, Fayoum University, Fayoum, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Psoriasis is an immune-mediated systemic and chronic disease that can affect males and females equally. Treatments of psoriasis may and may not be effective and is based on the patients' case and severity. There is currently no cure but treatments generally can help to control the symptoms. This work aims to compare the safety and efficacy of botulinum toxin as an intralesional injection versus topical steroid in treatment of plaque psoratic patients by evaluating the PASI score as well as the clinical improvement of the cases. Twenty patients with psoriasis vulgaris were included in the study where body was splitted into two bilaterally symmetrical psoriatic plaques and treated differently one side with single intradermal injecton of botulinum toxin and the other side with topical steroid. Both treatments showed significant decrease in PASI score in two and four weeks of treatment and follow-up. There was no significant difference between the two methods; however there were small changes in the results of the score and on skin generally. Improvement of psoriasis vulgaris lesions with botulinum toxin as single application with a high safety profile proposes a good target in psoriasis vulgaris treatment; however, more investigations showed be considered.

Indexed as

Botulinum Toxins, Type APsoriasisAdministration, TopicalAdultFemaleHumansInjections, IntradermalInjections, IntralesionalMaleMiddle AgedSeverity of Illness IndexTreatment OutcomeBotulinum Toxins, Type ABotulinum toxinPsoriasis vulgarisTopical steroid

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.